Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 vs 3 cycles of neoadjuvant chemotherapy in N2-3 nasopharyngeal carcinoma
NCT04061278Phase 3Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nasopharyngeal carcinoma (NPC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04061278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061278.